Fennec Pharmaceuticals Inc (FENC)

Cost of Revenue

$3.72M

TTM · Period ending: · USD

FENC logo

FENC Cost of Revenue

Latest reported$3.72M
FENC TTM Cost of Revenue ($0.00 → $3.72M)
High-resolution chart · PNG

FENC cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fennec Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
3,715,000
3,961,000
3,764,000
2,669,000
3,366,000
3,007,000
3,184,000
3,200,000
2,174,000
1,714,000
1,259,000
574,000
243,000
95,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.